Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #2306 on Actinium Pharmaceuticals Inc (ATNM)
GoodGuyBill
07/25/20 4:46 PM
#2310 RE: Bluereaper #2306
Infusion administration of conjugated monoclonal antibodies Abstract A patient specific therapeutic composition provided in a single dose container, the total volume of which may be administered to a patient in a single treatment session. The composition includes a monoclonal antibody having a labeled fraction and an unlabeled fraction, and a pharmaceutically acceptable carrier. The label may be any of a radioisotope or a drug such as a chemotherapeutic or cytotoxic agent. The amount of the monoclonal antibody and any conjugated label molecule may depend on at least one patient specific parameter selected from a patient weight, a patient age, a patient height, a patient gender, a patient medical condition, and a patient medical history. Methods of administration, production, and articles of manufacture comprising the patient specific therapeutic composition are also disclosed.